Small Molecules
29 April 2014
GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria29 April 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD29 April 2014
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 01129 April 2014
CHMP recommends EU label expansion of Novartis’ Gilenya and data at AAN confirm efficacy on pre-treated MS patients29 April 2014
Ohr Pharmaceutical Announces Completion of Enrollment in Phase II Clinical Trial of Squalamine Eye Drops in Wet-AMD25 April 2014
Sorafenib Recommended for Approval in the European Union for the Treatment of Differentiated Thyroid Cancer25 April 2014
GSK receives positive CHMP opinion for Mekinist™ (trametinib) in metastatic melanoma with a BRAF V600 mutation25 April 2014
Novartis’ INSTEAD study for Onbrez® Breezhaler® in patients with moderate COPD meets primary objective24 April 2014
Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson’s Disease22 April 2014
Evoke Pharma Initiates Phase 3 Clinical Trial of EVK-001 for Treatment of Gastroparesis22 April 2014
Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDANews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports